Your session is about to expire
← Back to Search
Proactive Tobacco Treatment for COPD
N/A
Waitlist Available
Led By Anne C. Melzer, MD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosed with COPD (2 ICD-10 diagnoses of COPD within the past 2 years)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial will test if a proactive, electronic tobacco treatment intervention can help smokers with COPD quit smoking.
Who is the study for?
This trial is for smokers with COPD who are veterans, currently enrolled in MyHealtheVet secure messaging, have had at least one medical visit in the past year, and are confirmed as current smokers. It's not for those already in VA tobacco treatment, non-English speakers, hospice patients, cancer patients under active treatment or individuals with advanced dementia.Check my eligibility
What is being tested?
The study is testing an electronic proactive outreach program designed to help smokers with COPD quit smoking. The program will be delivered via text or secure messaging instead of phone calls. Participants will either receive usual care or the new intervention to see if it increases engagement in quitting programs and success rates.See study design
What are the potential side effects?
Since this trial involves a behavioral intervention rather than medication, there aren't typical drug side effects. However, participants may experience stress or frustration related to quitting smoking efforts.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with COPD twice in the last 2 years.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Response to outreach intervention
Secondary outcome measures
Marginal Cost
Number of Quit attempts
Participation in tobacco cessation treatment
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Proactive OutreachExperimental Treatment1 Intervention
Randomly assigned sample who will receive a proactive offer of tobacco treatment with connection to motivational texting program.
Group II: Usual CareActive Control1 Intervention
Randomly assigned sample who will receive usual care for tobacco cessation treatment
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Proactive Outreach
2010
N/A
~20980
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,483 Total Patients Enrolled
9 Trials studying Smoking
3,279 Patients Enrolled for Smoking
Anne C. Melzer, MDPrincipal InvestigatorMinneapolis VA Health Care System, Minneapolis, MN
Anne C. Melzer, MD MSPrincipal InvestigatorMinneapolis VA Health Care System, Minneapolis, MN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently receiving treatment for cancer.You have been identified as a current smoker in your medical records within the past year.I cannot communicate in English.You are currently receiving end-of-life care in a hospice.You are already taking part in a VA program to help you quit smoking.My condition is advanced dementia.I have been diagnosed with COPD twice in the last 2 years.Veterans who have had at least one visit to a primary care or pulmonary doctor in the past year.
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care
- Group 2: Proactive Outreach
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this research program offer participation opportunities to individuals?
"Clinicaltrials.gov does not indicate that this trial is currently accepting patients, as the last update was on May 10th 2022 and it had first been posted on September 1st 2020. Nevertheless, there are 528 other medical studies in progress that may be of interest to prospective participants."
Answered by AI
Who else is applying?
What state do they live in?
Minnesota
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
Recent research and studies
Share this study with friends
Copy Link
Messenger